Researchstore.biz launched a study titled “Global Wound Care Biologics Market by Product (Biological Skin Substitutes, Topical Agents), Wound Type (Ulcer, Surgical & Traumatic Wound, Burns), End User (Hospitals, Ambulatory Surgical Centers, Burn Centers, Wound Clinics), Region (North America, Europe, Asia Pacific, South America and Middle East and Africa)” and Global Forecast 2018-2025.
The global wound care biologics market is expected to grow from USD 1.92 billion in 2017 to USD 4.21 billion by 2025 at a CAGR of 10.28% during the forecast period from 2018-2025. Major drivers that fuel the growth of Wound care biologics market are:
- Rising occurrences of burn injuries
- Speedy growth in the senior population
- Increasing incidence of ulcers and target conditions
- Modernization in wound care treatments
- Government interest in promoting awareness regarding the wound care treatment and management
To Get Free Sample Report Visit @ https://researchstore.biz/report/global-wound-care-biologics-market/79982/#requestforsample
The burns are more prominent injuries that account nearly 5-12% of all the injuries occurring worldwide. The wound care biologics are primarily focus on appropriate wound healing and effective infection control. The biologics promote the growth of blood vessels within the healing tissue and thus helps in prevention of risky problems such infection, hospitalization, and amputation of wound. The wound care biologics is used for non-mending wounds of the lower extremity and is slowly replacing the old traditional methods of wound care.
Rising occurrences of burn injuries and speedy growth in the senior population is anticipated to drive Wound care biologics market:
Rising occurrences of burn injuries, speedy growth in the senior population, and increasing incidence of ulcers and target conditions are the key driving factors for the wound care biologics market. In addition, modernization in wound care treatments and government interest in promoting awareness regarding the wound care treatment and management will lead the growth of wound care biologics market in couple of years. Costly treatments of wound & wound care biologics and high risk of skin substitute failure may limit the growth of market. However, new innovative technologies and research on advanced wound treatments and introduction of 3d skin printing technology is expected to boost the wound care biologics market over the forecast period.
The global wound care biologics market is segmented on the basis of product, wound type, end user, and regions.
Ulcers segment valued around USD 693.89 Million in 2017
Wound type segment includes ulcer, surgical & traumatic wound, and burns. Ulcer segment is anticipated to grow with highest CAGR over the forecast period. The increasing rate of diabetic foot ulcers and venous leg ulcers is expected to drive the demand of ulcer segment. Additionally, the complex burn injuries due to negligence or accidents are also the prominent factor for the growth of the market.
Hospitals segment held market share of 29.71% in 2017
End user segment covers hospitals, ambulatory surgical centers, burn centers, and wound clinics. Hospitals segment is anticipated to grow with highest CAGR due to the availability of various types of wound care biologics services and treatments. The affordable treatment services in various hospitals and increasing government based hospitals in the regions is also the key factor for the growth of the hospitals segment.
Regional Segmentation Analysis:
The market is analysed on the basis of five regions namely North America, Europe, Asia Pacific, South America, and Middle East and Africa. North America held the largest market share of approximately 30% in 2017. The presence of major players, high prevalence of ulcers wound people, and the technological advancements were some of the factors that led to the growth of wound care biologics market in this region.
The major players for wound care biologics market include Mölnlycke Health Care AB, Solsys Medical, Lavior Inc., Marine Polymer Technologies, Integra LifeSciences Corporation, Wright Medical, Smith & Nephew, MiMedx Group, Vericel Corporation, Organogenesis, Kerecis, Anika Therapeutics, ACell, and among others.
To Get Complete Information Visit @ https://researchstore.biz/report/global-wound-care-biologics-market/79982/
Wound care biologics market is segmented into the following submarkets:
Wound Care Biologics Market by Product:
- Biological Skin Substitutes
- Human Donor Tissue-derived Products
- Acellular animal-derived Products
- Biosynthetic Products
- Topical Agents
Wound Care Biologics Market by Wound Type:
- Diabetic Foot
- Surgical & Traumatic Wound
Wound Care Biologics Market by End User:
- Ambulatory Surgical Centers
- Burn Centers
- Wound Clinics
Wound Care Biologics Market by Regions:
- NORTH AMERICA
- SOUTH AMERICA
- MIDDLE EAST AND AFRICA
Do Inquiry Before Buying @ https://researchstore.biz/report/global-wound-care-biologics-market/79982/#inquiry
*All our reports are customizable as per customer requirements. Please connect with our sales team (firstname.lastname@example.org).